Koen Deforche

5.8k citations

40 papers · 2.3k indexed · 1 hit paper · h-index 18

Infectious Diseases top 0.5%
Virology top 0.5%
Epidemiology top 10%
Cardiology and Cardiovascular Medicine top 5%
Molecular Biology

Co-authors: Anne–Mieke Vandamme Ricardo Camacho Annelies Kroneman M. Steven Oberste Harrie van der Avoort Marion Koopmans Silvia Peñaranda Harry Vennema
Topics: HIV Research and Treatment (26 papers)HIV/AIDS drug development and treatment (24 papers)HIV/AIDS Research and Interventions (7 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: Nucleic Acids Research Bioinformatics PLoS ONE
Partner nations: Belgium Portugal United States

In The Last Decade

Koen Deforche

38 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An automated genotyping tool for enteroviruses and noroviruses

2011 625 citations Annelies Kroneman, Harry Vennema et al. Journal of Clinical Virology profile →

Peers

Countries citing papers authored by Koen Deforche

Since Specialization

Citations

This map shows the geographic impact of Koen Deforche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Deforche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Deforche more than expected).

Fields of papers citing papers by Koen Deforche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Deforche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Deforche. The network helps show where Koen Deforche may publish in the future.

Co-authorship network of co-authors of Koen Deforche

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Deforche. A scholar is included among the top collaborators of Koen Deforche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Deforche. Koen Deforche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes 2020 ·Bioinformatics ·(unknown),(unknown),Vagner Fonseca,(unknown),Marta Giovanetti,Luíz Carlos Júnior Alcântara,Koen Deforche,Túlio de Oliveira	83
2	SANTA-SIM: simulating viral sequence evolution dynamics under selection and recombination 2019 ·Virus Evolution ·(unknown),(unknown),Koen Deforche,Pieter Libin,Alexei J. Drummond,Andrew Rambaut,F. A. Matsen,Kristof Theys	18
3	VIRULIGN: fast codon-correct alignment and annotation of viral genomes 2018 ·Bioinformatics ·Pieter Libin,Koen Deforche,Ana Abecasis,Kristof Theys	40
4	Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: Performance evaluation of the new REGA version 3 and seven other tools 2013 ·Infection Genetics and Evolution ·Andrea-Clemencia Pineda-Peña,Nuno R. Faria,Stijn Imbrechts,Pieter Libin,Ana Abecasis,Koen Deforche,Arley Gómez-López,Ricardo Camacho,Túlio de Oliveira,Anne–Mieke Vandamme	285
5	APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete “All or Nothing” Phenomenon 2012 ·PLoS Genetics ·Andrew E. Armitage,Koen Deforche,Chih‐Hao Chang,Edmund G. Wee,Beatrice Kramer,John J. Welch,Jan Gerstoft,Lars Fugger,Andrew J. McMichael,Andrew Rambaut,Astrid K. N. Iversen	60
6	An automated genotyping tool for enteroviruses and norovirusesbreakdown → 2011 ·Journal of Clinical Virology ·Annelies Kroneman,Harry Vennema,Koen Deforche,Harrie van der Avoort,Silvia Peñaranda,M. Steven Oberste,Jan Vinjé,Marion Koopmans	625
7	A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences 2009 ·Nucleic Acids Research ·Luíz Carlos Júnior Alcântara,S Cassol,Pieter Libin,Koen Deforche,Oliver G. Pybus,Marc Van Ranst,Bernardo Galvão‐Castro,Anne–Mieke Vandamme,Túlio de Oliveira	127
8	Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates 2008 ·Journal of Antimicrobial Chemotherapy ·(unknown),(unknown),Ana Abecasis,Kristel Van Laethem,(unknown),Koen Deforche,Amílcar Tanuri,Ricardo Camacho,Anne–Mieke Vandamme,Marcelo A. Soares	14
9	HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments 2008 ·Virology Journal ·Yung Shwen Ho,Ana Abecasis,Kristof Theys,Koen Deforche,Dominic E. Dwyer,Michael Charleston,Anne–Mieke Vandamme,Nitin K. Saksena	12
10	Bayesian network analyses of resistance pathways against efavirenz and nevirapine 2008 ·AIDS ·Koen Deforche,Ricardo Camacho,(unknown),Marcelo A. Soares,Kristel Van Laethem,David Katzenstein,P. Richard Harrigan,Rami Kantor,Robert W. Shafer,Anne–Mieke Vandamme	20
11	The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir☆ 2008 ·Infection Genetics and Evolution ·Kristof Theys,Jurgen Vercauteren,Ana Abecasis,Pieter Libin,Koen Deforche,Anne–Mieke Vandamme,Ricardo Camacho	7
12	Estimating the Relative Contribution of dNTP Pool Imbalance and APOBEC3G/3F Editing to HIV Evolution In Vivo 2007 ·Journal of Computational Biology ·Koen Deforche,Ricardo Camacho,Kristel Van Laethem,Beth Shapiro,Yves Moreau,Andrew Rambaut,Anne–Mieke Vandamme,Philippe Lemey	25
13	Predicting ordered accumulation of mutations of HIV under treatment using an estimate of the HIV in vivo fitness function during treatment 2006 ·Antiviral Therapy ·Koen Deforche,R Camacho,Kristel Van Laethem,Philippe Lemey,Yves Moreau,Anne–Mieke Vandamme	1
14	Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance 2006 ·Bioinformatics ·Koen Deforche,Tomi Silander,Ricardo Camacho,Zehava Grossman,Marcelo A. Soares,Kristel Van Laethem,Rami Kantor,Yves Moreau,Anne–Mieke Vandamme,(unknown)	59
15	HIV-1 subtype A1, C, F and G strains have a higher tipranavir mutation score than subtype B strains 2005 ·Antiviral Therapy ·Anne–Mieke Vandamme,Koen Deforche,Kristel Van Laethem,Ricardo Camacho	2
16	Substitution of methionine at position 89 of the protease gene by other amino-acids occurs differentially during selection of particular resistance pathways in subtype C-patients 2005 ·Antiviral Therapy ·Zehava Grossman,Shlomo Maayan,Diana Averbuch,(unknown),H Rudich,Daniel R. Ram,Ella Mendelson,Koen Deforche,Anne–Mieke Vandamme,(unknown)	2
17	A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes 2005 ·Journal of Virological Methods ·Kristel Van Laethem,Yoeri Schrooten,(unknown),(unknown),Koen Deforche,Eric Van Wijngaerden,Marc Van Ranst,Anne–Mieke Vandamme	15
18	An automated genotyping system for analysis of HIV-1 and other microbial sequences 2005 ·Computer applications in the biosciences ·(unknown),Koen Deforche,S Cassol,Mika Salminen,Dimitrios Paraskevis,Christopher J. Seebregts,J. Snoeck,Elizabeth J. van Rensburg,Annemarie M. J. Wensing,David van de Vijver,Charles A. Boucher,Ricardo Camacho,Anne–Mieke Vandamme	412
19	Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method 2005 ·Infection Genetics and Evolution ·Dimitrios Paraskevis,Koen Deforche,Ana Abecasis,Ricardo Camacho,Anne–Mieke Vandamme	1
20	Nelfinavir resistance in HIV-1 subtype B and G infected patients: evidence for different pathways and novel mutations associated with failure of nelfinavir based regimens 2004 ·Antiviral Therapy ·R Camacho,Koen Deforche,(unknown),Kristel Van Laethem,(unknown),Jaime H. Vera,(unknown),(unknown),(unknown),Irene S. Soares,Teresa Branco,(unknown),Eugénio Teófilo,(unknown),Ana Abecasis,(unknown),(unknown),Anne–Mieke Vandamme	3

About Koen Deforche

Koen Deforche is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 40 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (24 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.8k citations) and Hepatology (259 citations). Koen Deforche has collaborated with scholars based in Belgium, Portugal and United States. Frequent co-authors include Anne–Mieke Vandamme, Ricardo Camacho, Annelies Kroneman, M. Steven Oberste, Harrie van der Avoort, Marion Koopmans, Silvia Peñaranda, Harry Vennema, Jan Vinjé and Túlio de Oliveira. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact